The HIV oncology service at UCLH treats all patients with HIV-related cancers.
Clinics are held in the Cancer Centre, close to University College Hospital, where patients are seen by oncologists specialising in HIV-related cancers, and an HIV consultant.
The clinic runs once a week on Thursday. Patients also receive their chemotherapy treatment in the same building.
The service also provides a high dose chemotherapy and peripheral blood stem cell transplantation program for relapsed HIV lymphoma and Hodgkin’s Disease.
The department initiated the policy of treating HIV-associated multicentric Castleman disease with HAART, sparing patients unnecessary chemotherapy with attendant toxicity.
The oncologists and clinical nurse specialist (CNS) liaise closely with local HIV clinicians at the Mortimer Market Centre, supervising their antiretroviral therapy, and with clinical oncologists providing radiotherapy treatments where appropriate.
The department has established a HIV-related cancer Biobank with UCL Cancer Institute for HIV Research.
People infected with HIV have a substantially higher risk of some types of cancer than uninfected people. Three of these cancers are known as AIDS-defining malignancies: Kaposi's sarcoma, non-Hodgkin’s lymphoma, and cervical cancer.
In addition, people infected with HIV are also at higher risk of several other types of cancer. These 'non-AIDS-defining cancers' include Hodgkin’s lymphoma, anal cancer, liver cancer, and lung cancer.
All patients are seen in clinic within two weeks of referral.